Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-10.57 Insider Own0.20% Shs Outstand332.17M Perf Week4.66%
Market Cap81.87B Forward P/E13.75 EPS next Y17.92 Insider Trans-9.69% Shs Float332.17M Perf Month9.95%
Income-3688.70M PEG- EPS next Q3.94 Inst Own87.80% Short Float2.05% Perf Quarter3.85%
Sales14.74B P/S5.55 EPS this Y63.30% Inst Trans-5.45% Short Ratio2.97 Perf Half Y27.05%
Book/sh209.66 P/B1.18 EPS next Y11.46% ROA8.90% Target Price271.72 Perf Year5.55%
Cash/sh26.95 P/C9.15 EPS next 5Y12.38% ROE15.90% 52W Range184.50 - 261.27 Perf YTD17.36%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI0.10% 52W High-5.67% Beta1.17
Dividend %1.14% Quick Ratio1.20 Sales past 5Y26.00% Gross Margin87.60% 52W Low33.58% ATR3.37
Employees16700 Current Ratio1.30 Sales Q/Q5.10% Oper. Margin-17.40% RSI (14)75.52 Volatility1.84% 1.29%
OptionableYes Debt/Eq0.45 EPS Q/Q- Profit Margin80.50% Rel Volume2.23 Prev Close247.11
ShortableYes LT Debt/Eq0.37 EarningsAug 08 BMO Payout2.40% Avg Volume2.29M Price246.46
Recom2.10 SMA206.51% SMA505.70% SMA2009.20% Volume5,106,002 Change-0.26%
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Jun-23-17 01:32PM  Top Stock Reports for Oracle, Allergan & Abbott Zacks
Jun-21-17 02:23PM  Todd Hagopian's Top 2 Mental Health Biotech Stocks Forbes
Jun-20-17 07:01PM  Cramer: If There's No Reason for a Rally, Then Something's Wrong TheStreet.com
07:36AM  Key Updates on Eli Lillys Jardiance Market Realist
07:11AM  Novartis eye drug works with fewer injections than rivals Reuters
Jun-19-17 02:39PM  Allergan Is Putting the Bull Back in Charge TheStreet.com
01:47PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Isnt Healed by Paulsons Presence InvestorPlace
Jun-18-17 02:03PM  Could Legalized Marijuana Be Making Big Pharma Nervous? Motley Fool
Jun-15-17 03:42PM  5 Things Allergan's Management Just Said That You Need to Know Motley Fool
01:38PM  Allergan CEO on the battle over drug pricing CNBC Videos
08:13AM  Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : June 15, 2017 Capital Cube
Jun-11-17 02:27PM  Opioid Stocks Feel the Pressure of FDA Measures Investopedia
Jun-09-17 12:02PM  New migraine drugs have promise and a $8,500 price tag MarketWatch
Jun-08-17 12:54PM  Valeant Pharmaceuticals: Bigger is Better Barrons.com
10:05AM  Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit Zacks
Jun-07-17 10:54AM  Alkermes Gets FDA Nod for Two Month Dose of Aristada Zacks
09:00AM  Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab PR Newswire
08:43AM  Allergan to buy medical device company and breast surgery funnel-maker Keller Medical Inc. MarketWatch
08:30AM  Allergan to Acquire Keller Medical, Inc., Adding Keller Funnel® to Company's Leading Plastic Surgery Portfolio PR Newswire
07:31AM  Allergan to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston PR Newswire
Jun-05-17 02:01PM  Goldman Reveals Top Stocks Owned By Hedge Funds This Year Investopedia
09:01AM  Is Ironwood's Growth About to Slow? Motley Fool
08:15AM  Featured Company News - Mylan Launches Two New Generic Drugs: Generic Reclast® Injection and Generic Azilect® Tablets Accesswire
Jun-02-17 08:00AM  Allergan to Present at the Goldman Sachs Global Healthcare Conference PR Newswire
Jun-01-17 01:06AM  PRESS DIGEST - Wall Street Journal - June 1 Reuters
May-31-17 03:08PM  Ohio attorney general sues 5 drugmakers over opiate crisis Associated Press
02:43PM  [$$] Ohio sues drugmakers over US opioid addiction crisis Financial Times
02:33PM  Ohio Going After Drug Makers for Fueling Opioid Crisis TheStreet.com
01:33PM  Leon Cooperman Bets On These 19 Stocks Forbes
12:10PM  Johnson and Johnson, other drug companies accused of viol... CNBC Videos
08:00AM  Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans PR Newswire
May-30-17 12:18PM  Key Moves by Billionaire David Tepper's Appaloosa Mgmt in Q1: 13F Filings Investopedia
12:13PM  Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 Investopedia
May-26-17 07:00AM  Allergan Announces Closing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-25-17 02:13PM  Aerie's Ophthalmic Candidate Positive in Registration Trial Zacks
02:01PM  TrumpCare isn't moving health care stocks because it won't pass: NYSE trader Yahoo Finance Video
07:55AM  Getting Struck Twice: Acquisitions & Spinouts In Biotech Forbes
May-24-17 04:30PM  Allergan Announces Pricing of Tender Offers by Certain Subsidiaries PR Newswire
11:19AM  Shark Bites: Focus on the 'Little Picture' TheStreet.com
08:00AM  Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries PR Newswire
May-23-17 06:09PM  Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE (Oxymetazoline HCL) Cream, 1% PR Newswire
05:30PM  Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
03:01PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
02:33PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
01:26PM  Has Allergan's Pullback Run Its Course? TheStreet.com
10:51AM  Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's euro notes; stable outlook Moody's
06:00AM  These Big Drug Stocks May Cure the Trump Blues Investopedia
03:53AM  Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-22-17 08:27AM  3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter Motley Fool
05:28AM  European stocks edge higher as U.S. political commotion subsides MarketWatch
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
09:48AM  Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA Zacks
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks
09:59AM  Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss Zacks
07:20AM  Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan MarketWatch
May-16-17 01:40PM  Is Editas Facing a New Reality in CRISPR Land? 24/7 Wall St.
12:30PM  Cramer: Carl Icahn Was Right to Sell Apple at $95 TheStreet.com
12:30PM  Carl Icahn Was Right to Sell Apple at $95 TheStreet.com
09:34AM  Biotech Movers: Akebia, Editas, Novavax TheStreet.com
07:45AM  Allergan's Eyepowerment Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications PR Newswire
07:00AM  VIBERZI Now Approved in Canada for patients with irritable bowel syndrome with diarrhea (IBS-D) PR Newswire
May-15-17 08:41PM  Several top fund managers trim Allergan stakes in first quarter Reuters
05:59PM  John Paulson Takes A Shine To Telecom The Wall Street Journal
03:12PM  ETFs with exposure to Allergan Plc : May 15, 2017 Capital Cube
09:28AM  13-F Reveals Tepper's Big Bet on Bank of America Investopedia
08:00AM  Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire
01:00AM  Still an Allergan Fan; Oil Vey!: Doug Kass' Views TheStreet.com
May-14-17 11:26AM  Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-12-17 08:10PM  Earnings Are Still Calling the Tune: Cramer's 'Mad Money' Recap (Friday 5/12/17) TheStreet.com
06:20PM  High-profile Snap stakeholders revealed in filings Reuters
06:03PM  13-F Alert: Starboard Dumps Macy's; Appaloosa and Baupost Lighten up on Allergan Barrons.com
05:19PM  Tepper's Appaloosa Trims Bets on Pharmaceuticals The Wall Street Journal
04:08PM  Court Battle May Be Responsible For Drugmaker's 40% Spike Investor's Business Daily
03:25PM  Top Picks For The Rest Of 2017, Courtesy Of UBS Benzinga
11:38AM  Allergan Plc :AGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
08:49AM  Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study Zacks
May-11-17 04:07PM  Hologic Topples On 'Blip' In Breast Health, Body-Sculpting Unit Investor's Business Daily
10:36AM  Understanding Allergans Valuation after the 1Q17 Results Market Realist
09:59AM  Final Trades: Valeant, Allergan and more CNBC Videos
09:08AM  What Happened to Allergans International Segment in 1Q17? Market Realist
08:00AM  Today's Research Reports on Stocks to Watch: Allergan and Celgene Accesswire
07:37AM  Behind Allergans US General Medicines Segment in 1Q17 Market Realist
12:19AM  Asian stocks mostly higher in quiet trading; oil prices gain Associated Press
May-10-17 06:05PM  Behind Allergans US Specialized Therapeutics Segment in 1Q17 Market Realist
04:52PM  4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning Motley Fool
04:45PM  Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents Investor's Business Daily
04:24PM  Inside Allergans 1Q17 Results: Revenue Streams Market Realist
04:17PM  US STOCKS-Wall St mixed after Trump fires FBI head; Nasdaq hits record high Reuters
03:28PM  Allergan Starts 'Pivotal' 2017 With a Beat, Plus Jim Cramer's Take TheStreet.com
03:02PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
02:17PM  US STOCKS-Wall Street mixed after Trump fires FBI head Reuters
02:05PM  Allergan Looking Shaky After So-So Quarter Investopedia
01:00PM  US STOCKS-Tepid earnings, Comey sacking weigh on Wall St Reuters
11:59AM  Jim Cramer Discusses Disney, Yelp, Nvidia, Allergan, Abercrombie, Macy's and Kohl's TheStreet.com
11:25AM  US STOCKS-Wall St weighed down by weak earnings, Comey sacking Reuters
11:03AM  Jim Cramer on Allergan: There Are So Many Sellers Off the Goldman Downgrade TheStreet.com
11:01AM  Cramer: 5 Timeless Rules When a Stock Breaks Down TheStreet.com
10:04AM  Allergan Stock Falls on Declining U.S. Medicine Revenue, Goldman Downgrade TheStreet.com
08:52AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : May 10, 2017 Capital Cube
08:41AM  Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM